Breast Flashcards

1
Q

Symptoms of benign breast disease

A

Breast pain (mastalgia)
Breast lumps
Disorders of the nipple and periareolar region
Breast infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Causes of palpable breast lumps (female)

A
  • Cancer (older age)
  • Benign breast change (middle age)
  • Fibroadenoma (young adult)
  • Cysts
  • Abscess (rare
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Causes of gynecomastia

A
  • Puberty
  • Idiopathic
  • Drugs (cimentidine, digoxin, spironolactone, androgens or antiestrogens)
  • Cirrhosis or malnutrition
  • Primary hypogonadism
  • Testicular tumor
  • Secondary hypogonadism
  • Hyperthyroidism
  • Renal disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Breast cancer

A
Lifetime risk: 10-12% (1 in 8-10 women)
Incidence: 1. (6500 per year in Hungary)
Mortality:  2. (2200 per year in Hungary)
Main risks:
-	Family history (x2-5)
-	Precocious puberty (x1.7-2)
-	Late menopause (x1.3-2)
-	Nuliparty (x1.3-2)
Abount 20% of all deaths in women around 45 years of age is due to breast cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Asymptomatic breast cancer: screening

A
  • Mammography between age 45-65 every 2 years
  • Sensitivity 91-97% (false negative)
  • Specificity 87-97% (false positive)
  • 100 in 1000 screening are „not negative”
  • 3-4 in this 100 prooves to be cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Symptomatic Breast Cancer

A

Most frequent symptoms

  • Lumb (76%)
  • Swelling (8%)
  • Pain
  • Paget’s disease
  • Nipple retraction and/or discharge
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Triplet Diagnostic Procedure

A
  1. Physical examination (palpation of breast and axilla)
  2. Diagnostic imaging (mammography, ultrasound)
  3. Biopsy (FNA and/or core biopsy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pathological Classification of Invasive Epithelial Tumours

A
  • Invasive ductal carcinoma (70-75%)
  • Invasive lobular carcinoma (8-10%)
  • Medullary carcinoma (3-5%)
  • Mucinous carcinoma (2-3%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Surgical treatment of early breast cancer - Past and Present

A

Anatomically determined mechanical view –sometimes ended in ultraradical surgery

  • Biological view - reduced radical surgery (ablation + axillay block dissection)
  • Breast preserving surgery (wide tumour excision + sentinel node biopsy/axillary block dissection)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  • Breast Conserving Surgery + SNB/ABD:
A

Tumour size is less than 40 mm

- Excision with satisfactory safety zone
- Rest mammal tissue is esthetically acceptable  - tumour is not centrally located - Multicentrical, but in the same quadrant and radiotherapy accessible - In case of lobular hystology mammography excluded multicentricity - Radiotherapy is available
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Contraindications for BCT for invasive carcinoma

A
  • two or more primary tumors in separate quadrants of the breast
  • Persistent positive margins after surgical attempts
  • Pregnancy (except perhaps in 3rd trimester)
  • History of previous therapeutic irradiation to the breast
  • History of scleroderma or active SLE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Advanced Breast Cancer

A
  • In case of advanced breast cancer – without distant metastasis – better to start with chemo-radio-hormontherapy and operate after required regression
  • Advanced breast cancer – with distant metastasis and/or exulceration – can not be treated curatively but ablation is considerable for hygienic reasons
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

DCIS

A

ABD is not neccessary because the probability of occult metastasis is 1-2 %

  • stereotaxical biopsy in case of unpalpability
  • Size is more than 4 cm or multicentrical: ablation
  • Size between 2.5-4 cm: wide excision or ablation
  • Size less than 2.5 cm: wide excision
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

LCIS

A

increased risk of invasive tumour(6-18x) but not obligate precursor. Excision and close observation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Sentinel Lymph Node Biopsy

A
  • Peritumoural injection of Technecium isotope
  • Subareolar injection of Patent blue solution to visualize lymph nodes and vessels
  • Localisation of first (sentinel) lymph node with gamma camera (GPS locator) and excision
  • With this double marking technique the sentinel lymph node detection is successful in 96-98 % of cases.
  • Axillary block dissection should only be performed if intraoperative histology confirmes metastatic lymph nodes
  • Applicable if T1 or T2 less than 30 mm and preoperative nodal status is negative
  • If performed correctly and routinely clinical value is equal to ABD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Risk factors other than nodal status for survival

A
  • tumor size
  • tumor grade
  • estrogen receptor status
  • Presence of lymphatic/vascular invasion
  • Biological markers
17
Q

Rare appearances of breast cancer I

A
  1. Inflammatory BC: first treatment is non-surgical, after neoadjuvant therapy and regression palliative ablatio+ABD possible
  2. Pregnancy and BC: poor prognosis. In st. I-II. surgery then postop. therapy considering foetus. Advanced BC - chemo-radiotherapy.
  3. Male BC: mastectomy and ABD
  4. Occult cancer with axillary metastasis: ABD and chemo-radio-hormone therapy and observation.
  5. Paget carcinoma: if only mamilla is involved - mamillectomy and central excision of ducts (cone excision). If invasive component is also present – mastectomy and SNB/ABD.
18
Q

Reconstruction after Breast Cancer Surgery

A

Primary reconstruction: at the time of tumour removal
Delayed primary reconstruction: after tumour removal and histological results together with definitive surgery
Secondary reconstruction: 1-2 years after definitive surgery and adjuvant therapy if no recurrence is detectable.
Methods: prostesis, TRAM-, LD-flap, free fasciocutan flap